Biological Activity
This study developed CRD-PEG-T7, a prostate cancer-targeting gene delivery system featuring a disulfide-crosslinked arginine-aspartic acid peptide vector modified with T7 targeting ligands for selective pDNA delivery in PCa gene therapy.
In Vitro
No in vitro data are provided in the current product source. Contact us for further information.
In Vivo
No in vivo data are provided in the current product source. Contact us for further information.
References & source
Published experimental findings depend on the model and assay conditions. They do not guarantee equivalent performance in every application. For laboratory research use only.